Ankeet Bhatt, MD, is a research scientist at Kaiser Permanente Northern California and an associate physician at Kaiser San Francisco Medical Center.
Rapid Initiation of SGLT2 Inhibitors Improves Cost-Effectiveness of Therapy, with Ankeet Bhatt, MD, MBA
Ankeet Bhatt, MD, MBA, discusses a study he led from AHA 2024 examining the cost-effectiveness of dapagliflozin based on how soon therapy was initiated following diagnosis or hospitalization.
Read More